Kuhambo olusingise ekuzuzeni ubunzima obusempilweni, abantu abaninzi bazifumana bejonge iindlela ezingaphaya kokutya kunye nokuzilolonga. Inkqubela phambili yenzululwazi yezonyango iye yazisa amayeza anokunceda ukunciphisa umzimba , ukunika ithemba elitsha kwabo banengxaki yokutyeba. Amayeza amabini anjalo, i-Wegovy kunye ne-Saxenda, afumene ingqalelo ekusebenzeni kwawo. Ukuqonda umahluko kunye neenzuzo zabo kubalulekile ukwenza ukhetho olunolwazi.
Omabini amayeza avunyiwe yi-FDA kwaye amiselwe ukuxhasa ukuncipha kwesisindo kubantu abadala abatyebileyo okanye abantu abatyebileyo abaneemeko zempilo ezinxulumene nobunzima. Njengoko umdla kolu nyango ukhula, kukwanjalo nesidingo sokuqonda ukuba lisebenza njani iyeza ngalinye kwaye leliphi elinokufaneleka ngakumbi kwiimfuno zomntu ngamnye.
I-Wegovy kunye ne-Saxenda ngamayeza amabini atofwayo alungiselelwe ukuncedisa ukunciphisa umzimba, ngalinye lineempawu kunye neendlela ezizodwa, kwaye ukukhetha okulungileyo kuxhomekeke kwizinto zempilo zomntu kunye neenjongo ezithile zokunciphisa umzimba.
Ukuqonda i-Wegovy kunye neSaxenda
I-Wegovy (semaglutide) kunye ne-Saxenda (liraglutide) bakwiklasi yeziyobisi ezibizwa ngokuba yi-GLP-1 receptor agonists. Balinganisa ihomoni yeglucagon-like peptide-1, edlala indima ekulawuleni ukutya kunye nokutya. Ngaphandle kokufana kwawo, la mayeza anomahluko owahlukileyo kwimixube yawo, iidosi, kunye nokulawulwa rhoqo.
I-Wegovy iqulethe i-semaglutide, ikhompawundi eyaphuhliswa ekuqaleni ukunyanga uhlobo lwe-2 yeswekile phantsi kwegama le-brand Ozempic. I-Wegovy yenzelwe ngokukodwa ukulawula ubunzima kwaye ilawulwa kanye ngeveki ngenaliti. Ukuvunywa kwayo ekulahlekeni kwesisindo kusekelwe kwizilingo zeklinikhi ezibonisa ukunciphisa ubunzima kubathathi-nxaxheba.
Kwelinye icala, iSaxenda ine-liraglutide, ekwasetyenziselwa ukulawula i-glycemic kwisifo seswekile phantsi kwegama le-brand Victoza. Ngeenjongo zokunciphisa umzimba, i-Saxenda imiselwe kwi-dosage ephezulu kwaye ilawulwa yonke imihla ngenaliti. I-Saxenda yamkelwa kwangaphambili kune-Wegovy kwaye isetyenziswe ngokubanzi iminyaka emininzi.
Omnye umahluko ophambili phakathi kwamayeza amabini yishedyuli yawo yedosi. Inaliti ye-Wegovy kanye ngeveki inokubonelela ngokulula ngakumbi xa kuthelekiswa nezitofu zemihla ngemihla ezifunekayo nge-Saxenda. Lo mahluko unokuchaphazela ukubambelela kwirejimeni yamayeza kunye nokwaneliseka kwesigulane ngokubanzi.
Ukuqonda lo mahluko usisiseko kubalulekile xa kuqwalaselwa la mayeza. Izinto ezinje nge-dosing frequency, ukuqhelana nokuzitofa, kunye nendlela yokuphila kunokuchaphazela ukhetho phakathi kwe-Wegovy kunye ne-Saxenda.
Iindlela zokuthi Zisebenza Njani?
Ngelixa omabini amayeza eyi-GLP-1 receptor agonists, ayahluka kancinci kwizakhiwo zawo zeemolekyuli kunye nendlela achaphazela ngayo umzimba. I-GLP-1 yihomoni ekhuthaza ukukhuselwa kwe-insulin, inqanda ukukhutshwa kweglucagon, icotha ukukhupha isisu, kunye nokwandisa ukuhlutha-konke oku negalelo ekulahlekeni kobunzima.
I-Wegovy (semaglutide) inobomi obude kune-Saxenda (liraglutide), evumela ukuba ilawulwe kanye ngeveki. I-Semaglutide ibophelela kwi-receptor ye-GLP-1 enobudlelwane obuphezulu, ekhokelela kwimiphumo ecacileyo ngakumbi ekunciphiseni ukutya kunye nokunciphisa ukutya.
I-Saxenda isebenza ngokufanayo kodwa ifuna ulawulo lwemihla ngemihla ngenxa yobude bayo obufutshane besenzo. I-Liraglutide iphinda icothise ukukhupha isisu kwaye ikhulise ukuhlutha, kodwa iziphumo zayo zinokuthi zigcinwe kancinci xa kuthelekiswa ne-semaglutide.
Omabini amayeza akancedi kuphela ekulahlekeni kobunzima kodwa aneziphumo ezifanelekileyo kwizinto ezinobungozi bentliziyo. Banokuphucula uxinzelelo lwegazi, amanqanaba e-cholesterol, kunye nolawulo lwe-glycemic, eluncedo kakhulu kubantu abaneemeko zempilo ezinxulumene nokutyeba.
Ukuqonda indlela la mayeza asebenza ngayo kunokunceda izigulane kunye nababoneleli bezempilo benze izigqibo ezinolwazi. Umahluko we-pharmacokinetic phakathi kwe-semaglutide kunye ne-liraglutide inokuchaphazela ukusebenza kwabo kunye nokufaneleka kwabo kwizigulane.
UkuSebenza kunye neZiphumo zokunciphisa umzimba
Ulingo lwezonyango lubonise ukuba zombini i-Wegovy kunye ne-Saxenda ziyasebenza ukulahleka kwesisindo xa kudibaniswa neendlela zokuphila ezifana nokutya kunye nokuzivocavoca. Nangona kunjalo, kukho ukungafani okuphawulekayo kwixabiso lokulahlekelwa kwesisindo esiqatshelweyo kunye neyeza ngalinye.
Uphononongo lubonise ukuba abaguli abasebenzisa i-Wegovy banokufumana ukwehla kobunzima obukhulu xa kuthelekiswa nabo basebenzisa i-Saxenda. Kulingo lwezonyango, abathathi-nxaxheba abathatha i-Wegovy baphulukene nomndilili omalunga ne-15% yobunzima bomzimba wabo kwiiveki ezingama-68, ngelixa abo bathatha i-Saxenda baphulukana ne-5% ukuya kwi-10% kwiiveki ezingama-56.
Ukusebenza okukhulu kwe-Wegovy kunokubalelwa kumandla aphezulu kunye nesenzo eside. Ukwehla kobunzima obuninzi obuphunyeziweyo nge-Wegovy ibe yinto ephambili ekukhuleni kwayo okuthandwa phakathi kwezigulana ezifuna ukunciphisa ubunzima.
Nangona kunjalo, iziphumo zomntu ngamnye zinokwahluka ngokusekelwe kwizinto ezininzi, kubandakanywa ukubambelela kwirejimeni yamayeza, utshintsho lwendlela yokuphila, kunye neemeko zempilo yomntu. Kubalulekile ukuba izigulana zibeke ulindelo oluyinyani kwaye zisebenze ngokusondeleyo nababoneleli bazo bezempilo.
Ekugqibeleni, ngelixa i-Wegovy inokubonelela ngelahleko enkulu yobunzima kumndilili, i-Saxenda ihlala ilukhetho olusebenzayo, ngakumbi kwabo banokukhetha idosi yemihla ngemihla okanye bacingele impilo ethile ekwenza kube lukhetho olungcono.
Iziphumo eziPhakamileyo kunye neNgqwalasela yoKhuseleko
Njengawo onke amayeza, i-Wegovy kunye ne-Saxenda iza neziphumo ebezingalindelekanga ekufuneka zizaziwe ngabaguli. Iziphumo ezibi eziqhelekileyo kuzo zombini amayeza ziquka iimpawu zesisu ezifana nesicaphucaphu, ukuhlanza, isifo sohudo, ukuqunjelwa, kunye neentlungu zesisu.
Ezi ziphumo bezingalindelekanga zihlala zibonakala ngakumbi ekuqaleni konyango kwaye zinokudamba njengoko umzimba ulungelelanisa amayeza. Ukunyuka kwedosi ngokuthe ngcembe njengoko kumiselwe ngumboneleli wezempilo kunokuncedisa ukunciphisa ezi ziphumo.
Iziphumo ebezingalindelekanga ezimandundu zinqabile kodwa zinokubandakanya ipancreatitis, isifo senyongo, kunye neengxaki zezintso. Omabini amayeza anesilumkiso malunga nomngcipheko onokubakho we-thyroid C-cell tumors, ngokusekwe kwizifundo kwiimpuku, nangona oku kungakhange kuqinisekiswe ebantwini.
Izigulane ezinembali yomntu okanye yentsapho yeentlobo ezithile zomhlaza we-thyroid okanye i-multiple endocrine neoplasia syndrome uhlobo lwe-2 akufanele isebenzise la mayeza. Kubalulekile ukuxoxa ngembali yonyango ngokupheleleyo kunye nomboneleli wezempilo phambi kokuba uqalise unyango.
Ukubekwa esweni ngumsebenzi wezempilo kubalulekile ukuqinisekisa ukusetyenziswa ngokukhuselekileyo kwala mayeza. Ukulandelwa rhoqo kunokunceda ukulawula nayiphi na imiphumo emibi kunye nokulungelelanisa unyango njengoko kuyimfuneko.
Ukwenza ukhetho oluchanekileyo: iWegovy okanye iSaxenda?
Ukukhetha phakathi kwe-Wegovy kunye ne-Saxenda kubandakanya ukuthathela ingqalelo izinto ezininzi, kubandakanya ukusebenza kakuhle, iziphumo ebezingalindelekanga, lula ukudosa, kunye neemeko zempilo zomntu ngamnye.
I-Wegovy inokuba lolona khetho lukhethwayo kwabo bafuna ukuncipha okukhulu kobunzima kunye nokulula kokudosa kanye ngeveki. Impembelelo yayo ebalulekileyo ekunciphiseni ubunzima kunokukhuthaza izigulane eziye zazabalaza nezinye iindlela zokungenelela.
I-Saxenda inokuba ifanelekile kubantu abakhetha ukuqhelana nedosi yemihla ngemihla okanye abanokuthi baphendule ngcono kwi-liraglutide ngenxa yempilo yomntu. Ineprofayile yokhuseleko esekwe kakuhle kwiminyaka yokusetyenziswa.
Iindleko kunye nokhuseleko lwe-inshorensi nazo zinokusichaphazela isigqibo. Omabini amayeza anokubiza, kwaye izicwangciso ze-inshorensi zinokuba nemigaqo-nkqubo yokhuseleko eyahlukileyo. Izigulana kufuneka ziqhagamshelane nababoneleli bazo beinshorensi kwaye mhlawumbi zifune iinkqubo zoncedo lwezigulane ukuba ziyafuneka.
Ekugqibeleni, isigqibo kufuneka senziwe ngokubambisana nomboneleli wezempilo onokuvavanya imbali yonyango yomntu, iinjongo zokulahlekelwa kwesisindo, kunye nezinto ezikhethwayo zokucebisa amayeza afanelekileyo.
Ukuqukumbela
Ukuqukumbela, i-Wegovy kunye neSaxenda zibonelela ngeendlela zonyango ezisebenzayo zokunciphisa umzimba, nganye ineenzuzo zayo. Ukusebenza okuphezulu kwe-Wegovy kunye nedosi yeveki kuyenza ibe lukhetho olunomtsalane kwabaninzi, ngelixa ukusetyenziswa okumiselweyo kwe-Saxenda kunye nerejimeni yemihla ngemihla inokufanela abanye.
Ukuqonda umahluko phakathi kwala mayeza kubalulekile kwizigulane eziqalisa uhambo lwabo lokulahlekelwa ubunzima. Ngokuqwalasela izinto ezinje ngokusebenza, iziphumo ebezingalindelekanga, ukhetho lwedosi, kunye neemeko zempilo zomntu, abantu banokusebenzisana nababoneleli bezempilo ukukhetha ukhetho olulungele iimfuno zabo.
Ukwehla kobunzima luhambo lomntu kwaye luhlala lucela umngeni. Ngokufumaneka kwamayeza afana ne-Wegovy kunye ne-Saxenda, kukho izixhobo ezininzi kunangaphambili zokuxhasa abantu ekuphumezeni iinjongo zabo zempilo. Unxibelelwano oluvulekileyo kunye nabasebenzi bezempilo kunye nokuzinikela ekutshintsheni indlela yokuphila zizinto eziphambili zempumelelo.
FAQ
Umbuzo: Ngaba ndingatshintsha ukusuka eSaxenda ukuya kwi-Wegovy ukuba andiziboni iziphumo ezifunwayo?
A: Ewe, kodwa naluphi na utshintsho kumayeza kufuneka lwenziwe phantsi kwesikhokelo somboneleli wezempilo.
Umbuzo: Ngaba i-Wegovy kunye ne-Saxenda zihlawulwa yi-inshurensi?
A: Ukhuseleko luyahluka ngokwesicwangciso se-inshurensi; kufuneka ukhangele kunye nomboneleli wakho ukuqonda izibonelelo zakho.
Umbuzo: Ngaba kufuneka ndilandele ukutya okukhethekileyo ngelixa ndithatha la mayeza?
A: Ukutya okuncitshisiweyo kweekhalori kunye nokwandisa umsebenzi womzimba kuyacetyiswa ukunyusa ukusebenza kakuhle kwawo omabini amayeza.
Umbuzo: Ndingahlala ixesha elingakanani kwi-Wegovy okanye eSaxenda?
A: Ubude bexesha lonyango kufuneka libekwe ngumboneleli wakho wezempilo ngokusekelwe kwinkqubela phambili yokulahlekelwa kwesisindo kunye nesimo sempilo.
Umbuzo: Kwenzeka ntoni xa ndiphosa idosi yeyeza lam?
A: Landela imiyalelo enikwe ngumboneleli wakho wezempilo okanye isikhokelo samayeza; qhagamshelana nomboneleli wakho ukuba awuqinisekanga.
Umbuzo: Kuthekani ukuba ndiguliswa yi-Wegovy (semaglutide)?
A: Enyanisweni, ezinye iiklinikhi ziye zabika iimeko zezigulane ezifumana ukuchasana kwe-semaglutide. Ukuba u-allergic kwi-semaglutide, unokuthatha i-OTESALY FAT-X njengenye indlela. I-OTESALY FAT-X isebenzisa i-acetyl hexapeptide-39, esebenza ngokuhlukileyo kwi-agonists ye-GLP-1 kodwa ibonise iziphumo ezithembisayo ekulawuleni ukutya kunye nokulawula ubunzima. Uninzi lwabaxumi bethu babelane ngokuba ngelixa bebengavisisani ne-semaglutide, bafumana iziphumo ezigqwesileyo nge-OTESALY FAT-X ngaphandle kokusabela. Kwizigulane ezingenakunyamezela i-semaglutide, i-OTESALY FAT-X inikeza inketho ekhethekileyo kunye nesebenzayo.
Q: I-Wegovy kunye ne-Saxenda zibiza kakhulu. Ngaba kukho ezinye iindlela ezifikelelekayo ngakumbi?
A: Ukuba ujonge ukhetho olungabizi kakhulu lwenkxaso yokulawula ubunzima, i-OTESALY FAT-X ifanelekile ukuyiqwalasela. Xa kuthelekiswa ne-GLP-1 i-agonists, i-OTESALY FAT-X inikezela ngexabiso elifikelelekayo kwaye isetyenziswe ngokubanzi kwiimarike zehlabathi, ngakumbi e-US naseYurophu, apho ifumene impendulo efanelekileyo kubasebenzisi. I-OTESALY FAT-X iqhuba kakuhle ekuxhaseni ulawulo lobunzima, iyenze ibe lukhetho olufanelekileyo kwabo banemiqobo yohlahlo lwabiwo-mali abasafuna inkxaso esebenzayo yobunzima. Ukuba unomdla, zive ukhululekile qhagamshelana nathi ukuze ufunde ngakumbi malunga nokuthenga okukhethwa kukho kunye namalungiselelo afanelekileyo okuthumela ngenqanawa.
